German Chancellor Friedrich Merz says he expects the United States to uphold its trade commitments with Europe following the launch of a US tariff investigation into German drug pricing. In comments reported by multiple outlets, Merz pushes back against the probe, linking the issue to the terms of an EU trade agreement. He argues that the United States should act consistently with existing commitments rather than pursue new tariffs over Germany’s approach to drug prices. The discussion centers on the Trump administration’s decision to initiate the investigation and the implications for transatlantic trade relations. While the reports focus on Merz’s response, they do not include details of the tariff investigation’s scope, timeline, or potential outcomes. The accounts are aligned in describing the same sequence: a US probe into drug pricing is announced, and Merz responds by citing the EU’s trade pact as the basis for expecting the United States to follow through on its obligations.